SCHEMBL15580550

SCHEMBL15580550

Cc1cc2c([nH]1)c(=O)n(C)n2C

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.38
LPO P22079 1/20 0.38
PTGS1 P23219 1/20 0.38
KDM4E B2RXH2 3/20 0.37
ADORA2A P29274 3/20 0.36
ADORA2B P29275 3/20 0.36
CA1 P00915 1/20 0.35
MAPT P10636 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 1/20 0.33
GRIA1 P42261 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA3 P42263 1/20 0.31
GRIA4 P48058 1/20 0.31
DAO P14920 1/20 0.31
CECR2 Q9BXF3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL611873 0.76 ADORA2B (0.59) ADORA2AADORA2BMAPTALDH1A1
SCHEMBL27398195 0.64 ADORA2B (0.57) KDM4EADORA2AADORA2BMAPTALDH1A1
SCHEMBL22729820 0.63 BRD4 (0.42) SMN1; SMN2KDM4ECA1MAPTALDH1A1
SCHEMBL17975077 0.61 CECR2 (0.45) SMN1; SMN2KDM4ECA1ALDH1A1HPGD
SCHEMBL20927158 0.59 KDM4E (0.52) SMN1; SMN2LPOPTGS1KDM4ECA1
SCHEMBL21144481 0.58 HPGD (0.67) SMN1; SMN2KDM4EADORA2ACA1MAPT
SCHEMBL2632820 0.58 YTHDF2 (0.52) SMN1; SMN2LPOPTGS1KDM4ECA1
SCHEMBL12809489 0.58 GDA (0.39) SMN1; SMN2KDM4EADORA2AMAPTALDH1A1
SCHEMBL15030952 0.57 SMN1; SMN2 (0.31) SMN1; SMN2KDM4EMAPTALDH1A1
SCHEMBL10005933 0.57 HPGD (0.70) SMN1; SMN2KDM4EADORA2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2708538-B1 Process for preparing fused pyrimidine-dione derivatives, useful as as TRPA1 modulators GLENMARK PHARMACEUTICALS SA (CH) 2015-08-12 EP disclosed
EP-2708538-A1 Process for preparing fused pyrimidine-dione derivatives, useful as as TRPA1 modulators Glenmark Pharmaceuticals S.A. (CH) 2014-03-19 EP disclosed